Revvity (RVTY) Cash & Equivalents Growth (3y) (2012 - 2026)
Powered by 
Analysis
Revvity (RVTY) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -20.26% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 9.77% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -12.51% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -8.42% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 13.60% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 9.85% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 10.32% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 15.53% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -31.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -8.42% |
| Apr 5, 2026 | -27.60% |
| Dec 28, 2025 | 26.51% |
| Sep 28, 2025 | 32.46% |
| Jun 29, 2025 | 42.07% |
| Mar 30, 2025 | 20.22% |
| Dec 29, 2024 | 24.47% |
| Sep 29, 2024 | 37.57% |
| Jun 30, 2024 | 29.64% |
| Mar 31, 2024 | 0.33% |
| Dec 31, 2023 | 33.12% |
| Oct 1, 2023 | 63.88% |
| Jul 2, 2023 | 82.66% |
| Apr 2, 2023 | 126.49% |
| Jan 1, 2023 | 33.29% |
| Oct 2, 2022 | 0.65% |
| Jul 3, 2022 | 32.11% |
| Apr 3, 2022 | 69.58% |
| Jan 2, 2022 | 54.65% |
| Oct 3, 2021 | 46.74% |